Posted: December 17th, 2014

Managing Operations; nominated case study from their text (Samson & Singh, 2008)

Managing Operations; nominated case study from their text (Samson & Singh, 2008)

Order Description

All details are included in the attached file ‘Assessment Information’. Questions to be answered are at the end of the case file attached ‘Ass 1 CS1 Samson & Singh’.

Assessment 1 is a case study exercise.  Students are required to read the nominated case study from their text (Samson & Singh, 2008), and then address the seven questions provided at the end of the case study.  Additional reading and research, to support your text and notes, will be required to provide information relating the context of the case and the content of the case.

You are expected to use at least EIGHT (8) different academic sources to support your discussions; use your text and the cited references from eReserve to start your reference list, and then search through the academic databases to research additional material to support your discussions.  Remember to access the company’s website and also use this as a source to assist in answering the case questions.  Avoid internet sources that do not have the author’s name as well as the publisher.  Your text would be one source, and the company’s website below is two – so you only need another 6!

1.    Read the case:

Case Study CS 1 Innovation in the Biotechnology Sector: The case of IDT Australia. John Morgan. (see Samson & Singh, 2008: 409)

**PLEASE SEE OTHER FILE ATTACHED**

2.    View the company’s website and read the information provided:

IDT Australia’s website:   http://www.idtaus.com.au

This site provides a range of information, take time to make yourself familiar with this to assist you when answering the case questions. The information provided includes company, Board of Directors, Management, News, brochure; their services, financial information – annual reports, ASX announcements, Current share price, corporate governance.

3.    Complete the questions at the end of the case

ompaoa mama» an
m [mt/mm W ‘ _ 7
ll
thDLE WWW; MK 1″ x r ‘ A
q – 40%
Innovation “1 the Biotechnology P? 4
Sector: The Case of IDT Austral Ia
John Morgan
Introduction
Thi- lnxl it we of Drug Technology was a university-owned not-for-profit
organisation which operated as part of the College of Pharmacy in Victoria
since l‘)75. ll primarily gave academics and industry the chance to conduct
mun-ch and development together. In 1986, then a professor, Dr Graeme L.
Black-mun led a management buy-out of the assets of this consulting busi-
ness. ‘l’lu- company was listed on the Australian Stock Exchange in 1988 as
H )T.
From I 988 to the early 19905, there was a move away from an academic ori-
i’mni ion and towards a manufacturing focus. This was because the company
was commissioned to make active pharmaceutical ingredients (APIs) under
lung-mm manufacturing contracrs. As a result, the company integrated for-
ward from a licensor of technology to a production oriented company.

+ Add New Category

The company has a number of modern manufacturing facilities and lab-
Ul‘éllorics in Melbourne and is licensed by the Australian Therapeutic Goods
Administration (TGA) and the United States Food and Drug Administra-
likm (FDA) for the production of active pharmaceutical ingredients. IDT is
Unc oft-he few Australian-owned biotechnology companies that have secured
H )A :1 pproval, which gives it access to the large and lucrative pharmaceutical
market in the United States.
H )T has grown to become a highly successful company with strong inter-
national standing. It has built up an international reputation of excellence
1” the development and manufacture of anti-cancer drugs. Back in 1996,
409 i

PLACE THIS ORDER OR A SIMILAR ORDER WITH US TODAY AND GET AN AMAZING DISCOUNT 🙂